Nov 28, 2018 / Comment Letters

MedPAC comment on CMS’s proposed rule on requiring drug pricing transparency

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests

Oct 04, 2018 / Presentations

Opioids and alternatives in hospital settings: Payments, incentives, and Medicare data

Research Areas:

Drugs, Devices, and Tests, Hospitals

Sep 17, 2018 / Comment Letters

MedPAC comment on CMS’s proposed rule on hospital outpatient and ambulatory surgical center payment systems for CY 2019

Research Areas:

Ambulatory Care Settings, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Quality

Aug 31, 2018 / Comment Letters

MedPAC comment on CMS’s proposed rule on the ESRD PPS update for CY 2019 and DMEPOS Competitive Bidding Program

Research Areas:

Ambulatory Care Settings, Delivery System Reforms, Drugs, Devices, and Tests, Quality

Aug 30, 2018 / Comment Letters

MedPAC comment on CMS’s proposed rule on the physician fee schedule and other revisions to Part B for CY 2019

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests, Physicians And Other Health Professionals, Quality

Jul 03, 2018 / Comment Letters

MedPAC comment on HHS’s policy statement and RFI on the HHS blueprint to lower drug prices and reduce out-of-pocket costs

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests, Medicare Spending and Financing

Mar 01, 2018 / Chapters

Chapter 3: Hospital inpatient and outpatient services (March 2018 report)

Research Areas:

Hospitals, Medicare Spending and Financing, Quality

Oct 31, 2017 / Comment Letters

MedPAC comment on the CMS RFI on the Innovation Center’s new guiding principles and focus areas

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests, Private Plans

Sep 07, 2017 / Presentations

Background on pharmacy benefit managers and specialty pharmacies

Research Areas:

Drugs, Devices, and Tests

Sep 07, 2017 / Presentations

Primer on Medicare coverage policy

Research Areas:

Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests